Down Syndrome (DS) is a genetic disease involving a number of anatomical, physiological and cognitive impairments. More particularly it affects speech production abilities. This results in reduced intelligibility which has however only been evaluated auditorily. Yet, many studies have demonstrated that adding vision to audition helps perception of speech produced by people without impairments especially when it is degraded as is the case in noise. The present study aims at examining whether the visual information improves intelligibility of people with DS. 24 participants without DS were presented with VCV sequences (vowel-consonant-vowel) produced by four adults (2 with DS and 2 without DS). These stimuli were presented in noise in three modalities: auditory, auditoryvisual and visual. The results confirm a reduced auditory intelligibility of speakers with DS. They also show that, for the speakers involved in this study, visual intelligibility is equivalent to that of speakers without DS and compensates for the auditory intelligibility loss. An analysis of the perceptual errors shows that most of them involve confusions between consonants. These results put forward the crucial role of multimodality in the improvement of the intelligibility of people with DS.
IntroductionNeurodevelopment and related mental disorders (NDDs) are one of the most frequent disabilities among young people. They have complex clinical phenotypes often associated with transnosographic dimensions, such as emotion dysregulation and executive dysfunction, that lead to adverse impacts in personal, social, academic, and occupational functioning. Strong overlap exists then across NDDs phenotypes that are challenging for diagnosis and therapeutic intervention. Recently, digital epidemiology uses the rapidly growing data streams from various devices to advance our understanding of health’s and disorders’ dynamics, both in individuals and the general population, once coupled with computational science. An alternative transdiagnostic approach using digital epidemiology may thus better help understanding brain functioning and hereby NDDs in the general population.ObjectiveThe EPIDIA4Kids study aims to propose and evaluate in children, a new transdiagnostic approach for brain functioning examination, combining AI-based multimodality biometry and clinical e-assessments on an unmodified tablet. We will examine this digital epidemiology approach in an ecological context through data-driven methods to characterize cognition, emotion, and behavior, and ultimately the potential of transdiagnostic models of NDDs for children in real-life practice.Methods and analysisThe EPIDIA4Kids is an uncontrolled open-label study. 786 participants will be recruited and enrolled if eligible: they are (1) aged 7 to 12 years and (2) are French speaker/reader; (3) have no severe intellectual deficiencies. Legal representative and children will complete online demographic, psychosocial and health assessments. During the same visit, children will perform additionally a paper/pencil neuro-assessments followed by a 30-min gamified assessment on a touch-screen tablet. Multi-stream data including questionnaires, video, audio, digit-tracking, will be collected, and the resulting multimodality biometrics will be generated using machine- and deep-learning algorithms. The trial will start in March 2023 and is expected to end by December 2024.DiscussionWe hypothesize that the biometrics and digital biomarkers will be capable of detecting early onset symptoms of neurodevelopment compared to paper-based screening while as or more accessible in real-life practice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.